ADM, a vasodilating peptide known as a regulator in the pathophysiology of cardiovascular disease, was recently found to have the ability to promote the growth of subcutaneously transplanted sarcoma 180 tumor cells, and ADM inhibitors were shown to be useful for the management of sarcoma growth [54]. The gene discussed is ADM; the disease is neoplasm.